Specific immune biomarker monitoring in two children with severe IgA nephropathy and successful therapy with immunoadsorption in a rapidly progressive case.

Abstract

BACKGROUND:

Childhood IgA nephropathy (cIgAN) is one of the most common primary glomerulonephritides with the potential to evolve to kidney failure. IgAN is an autoimmune disease involving 3 key factors: galactose-deficient IgA1 (Gd-IgA1), anti-IgA1 autoantibodies, and soluble (s)CD89 IgA Fc receptor. These molecules and immune complexes have been described recently as potential biomarkers of disease progression in childhood IgAN but their evolution in time under immunosuppressive treatment remains unknown.

METHODS:

We performed a prospective study of two proliferative cIgAN patients by sequentially biomonitoring immune IgA complexes (sCD89-IgA, IgG-IgA), sCD89, and Gd-IgA1 and correlating them with clinical and histological outcome after treatment.

RESULTS:

After patient 1's treatment, a decrease in sCD89-IgA, IgG-IgA, and free sCD89 was linked to a decrease in proteinuria whereas eGFR (estimated glomerular filtration rate) and Gd-IgA1 levels remained stable. Patient 1 received tacrolimus and monthly intramuscular steroid injections of Kenacort for 10 months. At the end, a relapse induced an increase in proteinuria consistent with an increase of the 3 biomarkers. Patient 2 displayed rapidly progressive IgAN with crescents in more than 90% of glomeruli and received intense immunosuppression treatment associated with the immunoadsorption (IA) approach. During IA, proteinuria decreased rapidly, as well as levels of CD89-IgA, IgG-IgA, sCD89, and Gd-IgA1 biomarkers. After discontinuation of IA, proteinuria increased as well as IgG-IgA complexes whereas sCD89-IgA and sCD89 remained low. Further re-intensification of IA and addition of cyclophosphamide improved proteinuria again with reduced IgG-IgA. A second biopsy was performed showing a reduction of extracapillary proliferation to 6% of glomeruli and only 9% glomerulsoclerosis.

CONCLUSIONS:

In conclusion, sequential biomonitoring of Gd-IgA1, IgA-immune complexes, and sCD89 in cIgAN was found to be valuable, by correlating with clinical features and glomerular proliferative lesions in cIgAN. These biomarkers could represent useful tools to evaluate kidney injury without repeat kidney biopsies.

• Authors: Alexandra Cambier, Claire Dossier, Julien Hogan, Véronique Baudouin, Anne Maisin, Anne Couderc, Theresa Kwon, Patrick J Gleeson, Renato C Monteiro
• Journal: Pediatric nephrology (Berlin, Germany) (Pediatr Nephrol) Vol. 37 Issue 7 Pg. 1597-1603 (07 2022) ISSN: 1432-198X [Electronic] Germany
• PMID: 34997322 (Publication Type: Journal Article)
• Copyright: © 2021. The Author(s), under exclusive licence to International Pediatric Nephrology Association.

Chemical References

• Antigen-Antibody Complex
• Biomarkers
• Immunoglobulin A
• Immunoglobulin G
• Galactose

Topics

• Antigen-Antibody Complex
• Biomarkers
• Child
• Galactose (therapeutic use)
• Glomerulonephritis, IGA (complications, diagnosis, therapy)
• Humans
• Immunoglobulin A
• Immunoglobulin G
• Prospective Studies
• Proteinuria